Repositorio Dspace

Listar 02.01.01. Investigación y comunicación científica por autor "Abad, María-Teresa"

Listar 02.01.01. Investigación y comunicación científica por autor "Abad, María-Teresa"

Ordenar por:Orden:Resultados:

  • Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD study 
    Fernández, Ovidio; Molina, Aurea; Anido-Herranz, Urbano; Álvarez, Carlos; Girones, Regina; Gajate, Pablo; García-Domínguez, Rocio; Ros-Martínez, Silverio; Puente, Javier; Blasco, Sara; Ore-Arce, Martin; Noguerón-Martínez, Esther; Fernández-Freire, Ana; del-Pozo, Nieves; Cassinello, Javier; Lazaro-Quintela, Martin; Arranz, Fernando; Crespo, Guillermo; Abad, María-Teresa; Llorente, Mar; Sánchez-Hernández, Alfredo; Juan, María-José (SPRINGER INT PUBL AG, 2025-07-09)
    PURPOSE: Maintenance avelumab has shown improved overall survival compared to chemotherapy alone in first-line treatment of advanced urothelial carcinoma. This study evaluates real-world evidence of avelumab as first-line ...
  • Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD study 
    Fernández, Ovidio; Molina, Aurea; Anido-Herranz, Urbano; Álvarez, Carlos; Girones, Regina; Gajate, Pablo; García-Domínguez, Rocío; Ros-Martínez, Silverio; Puente, Javier; Blasco, Sara; Ore-Arce, Martín; Noguerón-Martínez, Esther; Fernández-Freire, Ana; del-Pozo, Nieves; Cassinello, Javier; Lazaro-Quintela, Martín; Arranz, Fernando; Crespo, Guillermo; Abad, María-Teresa; Llorente, Mar; Sánchez-Hernández, Alfredo; Juan, María-José (SPRINGER INT PUBL AG, 2025-07-09)
    PURPOSE: Maintenance avelumab has shown improved overall survival compared to chemotherapy alone in first-line treatment of advanced urothelial carcinoma. This study evaluates real-world evidence of avelumab as first-line ...

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta